Persistent cognitive fog and mood changes following COVID-19 infection may now have a measurable biological signature in the aging brain. This finding could reshape how clinicians approach long-term COVID complications and guide targeted therapeutic interventions for millions experiencing prolonged symptoms.
Using specialized PET imaging with [18F]FEPPA tracer, researchers detected significantly elevated neuroinflammation markers across seven distinct brain regions in older adults with Long COVID compared to healthy controls. The inflammatory signals appeared in the prefrontal cortex, temporal and parietal areas, occipital regions, hippocampus, thalamus, and cerebellum. Participants with Long COVID also demonstrated measurably higher depression and fatigue scores on standardized neuropsychiatric assessments after experiencing cognitive impairments for over six months post-infection.
This pilot investigation provides the first direct imaging evidence linking widespread brain inflammation to Long COVID's neuropsychiatric manifestations in adults over 60. The translocator protein (TSPO) binding pattern suggests activated microglia throughout critical cognitive and emotional processing networks. While the sample included only three Long COVID patients for brain imaging due to the specialized nature of TSPO binding genetics, the uniform elevation across all measured regions strengthens the neuroinflammation hypothesis.
The findings align with emerging research connecting systemic inflammatory responses to persistent neurological symptoms, though causality remains unestablished. Limitations include the small imaging cohort and cross-sectional design, preventing conclusions about inflammation's temporal relationship to symptoms. However, identifying quantifiable brain changes could accelerate development of anti-inflammatory treatments and provide objective biomarkers for tracking recovery in this growing patient population.